Skip to main content

Advertisement

SpringerLink
Log in

Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To explore the association between chronic prostatitis (CP) and the subsequent development of benign prostatic hyperplasia (BPH).

Methods

Data analyzed were medical claims of Taiwan’s National Health Insurance program. From 2010 to 2017, 3571 patients ≧20 years with CP diagnosed by certified urologists were enrolled. Patients with past BPH diagnosis and diagnosis of prostate cancer, inguinal hernia, interstitial cystitis, and urethritis in the past and within one year after the first CP diagnosis were excluded. Age-matched controls were randomly selected from all non-CP individuals of the same exclusion criteria in the study period with a CP/non-CP ratio of 1:4. The follow-up was made from the first CP diagnosis to death or the end of 2018. The endpoint was the newly diagnosed BPH. Cox proportional hazard regression model was used to estimate the hazard ratio (HR) and 95% confidence interval (CI) of BPH in association with CP.

Results

Over a maximum of 8 years of follow-up, 287 (8.03%) and 258 (0.43%) BPH events were noted for the CP and non-CP group, respectively, representing a covariate adjusted HR (aHR) of 4.30 (95% CI, 3.61–5.13). Younger patients tended to suffer from higher aHRs, especially those aged 20–39 years (aHR: 11.45, 95% CI, 5.12–25.64).

Conclusion

The Taiwan national health database indicated that CP patients had a significantly higher risk of developing BPH later than non-CP patients. Interestingly, the younger the CP is diagnosed (under 40), the greater the risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Availability of data and material

Not applicable.

Code availability

Not applicable.

References

  1. Krieger JN, Lee SW, Jeon J et al (2008) Epidemiology of prostatitis. Int J Antimicrob Agents 31(Suppl 1):S85. https://doi.org/10.1016/j.ijantimicag.2007.08.028

    Article  CAS  PubMed  Google Scholar 

  2. Khan FU, Ihsan AU, Khan HU et al (2017) Comprehensive overview of prostatitis. Biomed Pharmacother 94:1064–1076. https://doi.org/10.1016/j.biopha.2017.08.016

    Article  PubMed  Google Scholar 

  3. Collins MM, Stafford RS, O’Leary MP et al (1998) How common is prostatitis? A national survey of physician visits. J Urol 159:1224–1228. https://doi.org/10.1016/S0022-5347(01)63564-X

    Article  CAS  PubMed  Google Scholar 

  4. Litwin MS, McNaughton-Collins M, Fowler FJ Jr et al (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 162:369–375. https://doi.org/10.1016/s0022-5347(05)68562-x

    Article  CAS  PubMed  Google Scholar 

  5. Roberts RO, Lieber MM, Rhodes T et al (1998) Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology 51:578–584. https://doi.org/10.1016/S0090-4295(98)00034-X

    Article  CAS  PubMed  Google Scholar 

  6. Liang CZ, Zhang XJ, Hao ZY et al (2004) An epidemiological study of patients with chronic prostatitis. BJU Int 94:568–570. https://doi.org/10.1111/j.1464-410X.2004.05002.x

    Article  PubMed  Google Scholar 

  7. Lee SWH, Chan EMC, Lai YK (2017) The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. Sci Rep 7:7984. https://doi.org/10.1038/s41598-017-06628-8

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  8. Xu XF, Liu GX, Guo YS et al (2021) Global, regional, and national incidence and year lived with disability for benign prostatic hyperplasia from 1990 to 2019. Am J Mens Health 15:15579883211036786. https://doi.org/10.1177/15579883211036786

    Article  PubMed  PubMed Central  Google Scholar 

  9. Madersbacher S, Sampson N, Culig Z (2019) Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review. Gerontology 65:458–464. https://doi.org/10.1159/000496289

    Article  CAS  PubMed  Google Scholar 

  10. Gandaglia G, Briganti A, Gontero P et al (2013) The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int 112:432–441. https://doi.org/10.1111/bju.12118

    Article  PubMed  Google Scholar 

  11. De Nunzio C, Presicce F, Tubaro A (2016) Inflammatory mediators in the development and progression of benign prostatic hyperplasia. Nat Rev Urol 13:613–626. https://doi.org/10.1038/nrurol.2016.168

    Article  CAS  PubMed  Google Scholar 

  12. Ning X, Shi JP, Wu ZY et al (2003) A case-control study on the risk factors of benign prostatic hyperplasia in the suburb of Shenyang; article in Chinese. Zhonghua Liu Xing Bing Xue Za Zhi 24:276–280. https://rs.yiigle.com/cmaid/678920

  13. St Sauver JL, Jacobson DJ, McGree ME et al (2008) Longitudinal association between prostatitis and development of benign prostatic hyperplasia. Urology 71:475–479. https://doi.org/10.1016/j.urology.2007.11.155

    Article  PubMed  Google Scholar 

  14. Calogero AE, Burgio G, Condorelli RA et al (2019) Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. Aging Male 22:12–19. https://doi.org/10.1080/13685538.2018.1434772

    Article  PubMed  Google Scholar 

  15. Safarinejad MR (2008) Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older. Int Urol Nephrol 40:921–931. https://doi.org/10.1007/s11255-008-9338-7

    Article  PubMed  Google Scholar 

  16. Koh JS, Ko HJ, Wang SM et al (2015) The Relationship between depression, anxiety, somatization, personality and symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Psychiatry Investig 12:268–273. https://doi.org/10.4306/pi.2015.12.2.268

    Article  PubMed  Google Scholar 

  17. Peng YH, Huang CW, Liao WC et al (2017) Association between chronic obstructive pulmonary disease and increased risk of benign prostatic hyperplasia: a retrospective nationwide cohort study. BMJ Open 7:e015581. https://doi.org/10.1136/bmjopen-2016-015581

    Article  PubMed  PubMed Central  Google Scholar 

  18. Li WM, Pasaribu N, Lee SS et al (2018) Risk of incident benign prostatic hyperplasia in patients with gout: a retrospective cohort study. Prostate Cancer Prostatic Dis 21:277–286. https://doi.org/10.1038/s41391-018-0047-8

    Article  PubMed  Google Scholar 

  19. Peng YH, Huang CW, Chou CY et al (2020) Association between asthma and risk of benign prostatic hyperplasia: a retrospective population-based study. Aging Male 23:599–606. https://doi.org/10.1080/13685538.2018.1552253

    Article  PubMed  Google Scholar 

  20. Huang JF, Shen N, Zhao JM et al (2023) Relationship between severity of obstructive sleep apnea and benign prostatic hyperplasia. Sleep Breath 27:363–369. https://doi.org/10.1007/s11325-022-02617-y

    Article  PubMed  Google Scholar 

  21. Feghali CA, Wright TM (1997) Cytokines in acute and chronic inflammation. Front Biosci 2:d12-26. https://doi.org/10.2741/a171

    Article  CAS  PubMed  Google Scholar 

  22. Berry SJ, Coffey DS, Walsh PC et al (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474–479. https://doi.org/10.1016/s0022-5347(17)49698-4

    Article  CAS  PubMed  Google Scholar 

  23. Maserejian NN, Chen S, Chiu GR et al (2013) Incidence of lower urinary tract symptoms in a population-based study of men and women. Urology 82:560–564. https://doi.org/10.1016/j.urology.2013.05.009

    Article  PubMed  Google Scholar 

  24. Toh KL, Ng CK (2006) Urodynamic studies in the evaluation of young men presenting with lower urinary tract symptoms. Int J Urol 13:520–523. https://doi.org/10.1111/j.1442-2042.2006.01347.x

    Article  PubMed  Google Scholar 

  25. Chiancone F, Carrino M, Meccariello C et al (2019) The use of a combination of vaccinium macracarpon, Lycium barbarum L. and Probiotics (Bifiprost®) for the prevention of chronic bacterial prostatitis: a double-blind randomized study. Urol Int 103:423–426. https://doi.org/10.1159/000502765

    Article  CAS  PubMed  Google Scholar 

  26. Cai T, Gallelli L, Cione E et al (2021) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study. World J Urol 39:3433–3440. https://doi.org/10.1007/s00345-020-03580-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Zhang R, Chomistek AK, Dimitrakoff JD et al (2015) Physical activity and chronic prostatitis/chronic pelvic pain syndrome. Med Sci Sports Exerc 47:757–764. https://doi.org/10.1249/MSS.0000000000000472

    Article  PubMed  PubMed Central  Google Scholar 

  28. Gacci M, Sebastianelli A, Salvi M et al (2017) Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study. BMC Urol 17:22. https://doi.org/10.1186/s12894-017-0211-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Shih HJ, Tsai PS, Wen YC et al (2020) Hyperlipidemia patients with long-term statin treatment are associated with a reduced risk of progression of benign prostatic enlargement. Aging Male 23:354–361. https://doi.org/10.1080/13685538.2018.1487392

    Article  CAS  PubMed  Google Scholar 

  30. Vignozzi L, Gacci M, Cellai I et al (2013) Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. Prostate 73:789–800. https://doi.org/10.1002/pros.22623

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Ms. Chih-Hui Hsu for providing the statistical consulting services from the Biostatistics Consulting Center, Clinical Medicine Research Center, National Cheng Kung University Hospital.

Funding

No funding was received for conducting this study.

Author information

Authors and Affiliations

  1. Division of Urology, Department of Surgery, National Cheng Kung University Hospital Dou-Liou Branch, Yunlin, Taiwan

    Tsung-Yen Lin, I-Hung Chen & Yu-Chiao Lin

  2. Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    Tsung-Yen Lin, Han-Yu Weng, Chien-Hui Ou & Yu-Sheng Cheng

  3. Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    Chung-Yi Li

  4. Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan

    Chung-Yi Li

  5. Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan

    Chung-Yi Li

Authors
  1. Tsung-Yen Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I-Hung Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Han-Yu Weng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu-Chiao Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chien-Hui Ou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chung-Yi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yu-Sheng Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

TYL: protocol/project development, data collection or management, data analysis, manuscript writing/editing. IHC: data collection or management, manuscript writing/editing. HYW: data collection or management, manuscript writing/editing. YCL: data collection or management, manuscript writing/editing. CHO: data collection or management, manuscript writing/editing. CYL: Protocol/project development, manuscript writing/editing. YSC: protocol/project development, data collection, manuscript writing/editing.

Corresponding author

Correspondence to Yu-Sheng Cheng.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of National Cheng Kung University Hospital, Tainan, Taiwan (Date 2019.11.28/No. B-ER-108-346).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 183 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, TY., Chen, IH., Weng, HY. et al. Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study. World J Urol 42, 126 (2024). https://doi.org/10.1007/s00345-024-04820-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00345-024-04820-w

Keywords

Search

Navigation